Laurie Glimcher
Laurie Glimcher
Laurie Glimcher (pronunciation: LOR-ee GLIM-cher) is a renowned immunologist and academic administrator known for her significant contributions to the field of medicine and biomedical research.
Etymology
The name 'Laurie' is of Latin origin, derived from the laurel tree or sweet bay tree symbolic of honor and victory. The surname 'Glimcher' is of unknown etymology.
Career
Laurie Glimcher is the President and Chief Executive Officer (CEO) of the Dana-Farber Cancer Institute, a principal teaching affiliate of Harvard Medical School. She is also the Richard and Susan Smith Professor of Medicine at Harvard Medical School. Prior to joining Dana-Farber, Glimcher served as the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine in New York City and Provost for Medical Affairs of Cornell University.
Research
Glimcher's research primarily focuses on the molecular mechanisms underlying lymphocyte activation, a critical process in the body's immune response. She is best known for her discovery of a key transcription factor, T-bet, which plays a crucial role in the immune system's response to infections.
Related Terms
- Immunology: The branch of medicine and biology concerned with immunity.
- Lymphocyte: A type of white blood cell in the vertebrate immune system.
- Transcription factor: A protein that controls the rate of transcription of genetic information from DNA to messenger RNA.
External links
- Medical encyclopedia article on Laurie Glimcher
- Wikipedia's article - Laurie Glimcher
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski